9 completed. 9 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
Follow Barrett Esophagus: new trials by email Literature Review of Barrett Esophagus trials Research Report on Barrett Esophagus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy - Barrett Esophagus, Gastroesophageal Reflux Disease | Phase 1 | Completed | University of Wisconsin, Madison | 43 | 2022-11-30 | 2026-04-07 |
| Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus Multiplexed heptapeptides - Barrett Esophagus | Phase 1 | Completed | University of Michigan | 27 | 2018-05-10 | 2019-08-05 |
| Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions IV-administation of EMI-137, Molecular Fluorescence Endoscopy platform - Barrett Esophagus, Esophageal Cancer | Phase 1 | Completed | University Medical Center Groningen | 15 | 2017-02-09 | 2024-04-16 |
| A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract GI heptapeptide - Barrett's Esophagus | Phase 1 | Completed | University of Michigan | 60 | 2012-07-01 | 2015-10-08 |
| Esophageal Protocol for Detection of Neoplasia in the Digestive Tract GI heptapeptide - Barrett Esophagus, Esophageal Adenocarcinoma | Phase 1 | Completed | University of Michigan | 25 | 2011-02-01 | 2012-10-11 |
| Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus Endoscopy and pH study - Barrett's Esophagus, GERD | Phase 1 | Completed | Mayo Clinic | 16 | 2007-08-01 | 2013-01-17 |
| Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus placebo, defined green tea catechin extract - Barrett Esophagus | Phase 1 | Completed | National Cancer Institute (NCI) | 55 | 2005-11-01 | 2014-09-11 |
| Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus HPPH - Barrett's Esophagus, CIS | Phase 1 | Completed | Roswell Park Cancer Institute | 18 | 2003-03-01 | 2014-12-02 |
| Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus HPPH - Barrett's Esophagus, CIS | Phase 1 | Completed | Roswell Park Cancer Institute | 18 | 2000-08-01 | 2014-01-13 |
Adenocarcinoma Of Esophagus (2) · Gastroesophageal Reflux (2) · Esophageal Neoplasms (1) · Gastrointestinal Neoplasms (1)
Digestive System Diseases (9) · Esophageal Diseases (9) · Gastrointestinal Diseases (9) · Neoplasms (9) · Precancerous Conditions (9) · Deglutition Disorders (2) · Digestive System Neoplasms (2) · Esophageal Motility Disorders (2) · Neoplasms by Site (2) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1)
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (2) · Biopsy (1) · Endoscopy (1) · Endoscopy, Digestive System (1) · Specimen Handling (1) · linaclotide (1) · plecanatide (1) · polyphenon E (1)
University of Michigan (3) · Roswell Park Cancer Institute (2) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · University Medical Center Groningen (1) · University of Wisconsin, Madison (1)
United States (8) · Netherlands (1)
Hector Nava, MD (2) · Charles Lightdale (1) · Danielle Kim Turgeon, M.D. (1) · David S Weinberg (1) · G.M. van Dam, MD, PhD (1) · Prasad G Iyer, M.D. (1) · W.B. Nagengast, MD, PhD, PharmD (1)
N01CN35159 (1), P30CA013696 (1), P30CA014520 (1), UG1CA242635 (1)